Pacific Edge Limited (PEB.AX)
AUD 0.14
(0.0%)
AUD 0.14
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 11.8 Million NZD | 35.56% |
| 2023 | 8.7 Million NZD | 17.18% |
| 2022 | 7.42 Million NZD | 22.3% |
| 2021 | 6.07 Million NZD | 25.93% |
| 2020 | 4.82 Million NZD | 81.63% |
| 2019 | 2.65 Million NZD | -12.2% |
| 2018 | 3.02 Million NZD | 10.63% |
| 2017 | 2.73 Million NZD | 8.36% |
| 2016 | 2.52 Million NZD | 30.69% |
| 2015 | 1.93 Million NZD | 102.56% |
| 2014 | 953.17 Thousand NZD | -11.55% |
| 2013 | 1.07 Million NZD | 11.22% |
| 2012 | 968.83 Thousand NZD | 60.31% |
| 2011 | 604.34 Thousand NZD | -10.08% |
| 2010 | 672.11 Thousand NZD | 5.11% |
| 2009 | 639.44 Thousand NZD | -15.03% |
| 2008 | 752.52 Thousand NZD | 232.75% |
| 2007 | 226.15 Thousand NZD | -29.48% |
| 2006 | 320.7 Thousand NZD | 20.7% |
| 2005 | 265.7 Thousand NZD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 7.95 Million NZD | 0.0% |
| 2024 Q3 | 10.82 Million NZD | 36.14% |
| 2024 Q4 | 11.8 Million NZD | 9.02% |
| 2024 Q1 | 7.95 Million NZD | -2.43% |
| 2024 FY | 11.8 Million NZD | 35.56% |
| 2023 Q2 | 7.91 Million NZD | 0.0% |
| 2023 Q4 | 8.15 Million NZD | 0.0% |
| 2023 FY | 8.7 Million NZD | 17.18% |
| 2023 Q3 | 8.15 Million NZD | 2.98% |
| 2023 Q1 | 7.91 Million NZD | 14.6% |
| 2022 Q3 | 6.9 Million NZD | 5.03% |
| 2022 Q4 | 6.9 Million NZD | 0.0% |
| 2022 FY | 7.42 Million NZD | 22.3% |
| 2022 Q1 | 6.57 Million NZD | 8.23% |
| 2022 Q2 | 6.57 Million NZD | 0.0% |
| 2021 FY | 6.07 Million NZD | 25.93% |
| 2021 Q2 | 6.51 Million NZD | 0.0% |
| 2021 Q1 | 6.51 Million NZD | 35.05% |
| 2021 Q4 | 6.07 Million NZD | 0.0% |
| 2021 Q3 | 6.07 Million NZD | -6.75% |
| 2020 Q1 | 4.87 Million NZD | 83.47% |
| 2020 Q4 | 4.82 Million NZD | 0.0% |
| 2020 Q2 | 4.87 Million NZD | 0.0% |
| 2020 Q3 | 4.82 Million NZD | -1.01% |
| 2020 FY | 4.82 Million NZD | 81.63% |
| 2019 Q1 | 2.9 Million NZD | -3.83% |
| 2019 FY | 2.65 Million NZD | -12.2% |
| 2019 Q4 | 2.65 Million NZD | 0.0% |
| 2019 Q3 | 2.65 Million NZD | -8.7% |
| 2019 Q2 | 2.9 Million NZD | 0.0% |
| 2018 Q1 | 2.71 Million NZD | -0.82% |
| 2018 FY | 3.02 Million NZD | 10.63% |
| 2018 Q4 | 3.02 Million NZD | 0.0% |
| 2018 Q3 | 3.02 Million NZD | 11.54% |
| 2018 Q2 | 2.71 Million NZD | 0.0% |
| 2017 Q1 | 1.99 Million NZD | -20.98% |
| 2017 FY | 2.73 Million NZD | 8.36% |
| 2017 Q4 | 2.73 Million NZD | 0.01% |
| 2017 Q3 | 2.73 Million NZD | 37.11% |
| 2017 Q2 | 1.99 Million NZD | 0.0% |
| 2016 Q3 | 2.52 Million NZD | 35.81% |
| 2016 Q4 | 2.52 Million NZD | 0.0% |
| 2016 FY | 2.52 Million NZD | 30.69% |
| 2016 Q1 | 1.85 Million NZD | -3.77% |
| 2016 Q2 | 1.85 Million NZD | 0.0% |
| 2015 FY | 1.93 Million NZD | 102.56% |
| 2015 Q1 | 1.15 Million NZD | 20.65% |
| 2015 Q4 | 1.93 Million NZD | 0.0% |
| 2015 Q3 | 1.93 Million NZD | 67.89% |
| 2015 Q2 | 1.15 Million NZD | 0.0% |
| 2014 Q2 | 1.19 Million NZD | 0.0% |
| 2014 FY | 953.17 Thousand NZD | -11.55% |
| 2014 Q4 | 953.17 Thousand NZD | 0.0% |
| 2014 Q3 | 953.17 Thousand NZD | -19.9% |
| 2014 Q1 | 1.19 Million NZD | 10.43% |
| 2013 Q3 | 925.08 Thousand NZD | 0.0% |
| 2013 FY | 1.07 Million NZD | 11.22% |
| 2013 Q4 | 1.07 Million NZD | 16.48% |
| 2012 Q4 | 968.83 Thousand NZD | 0.0% |
| 2012 FY | 968.83 Thousand NZD | 60.31% |
| 2011 FY | 604.34 Thousand NZD | -10.08% |
| 2011 Q4 | 604.34 Thousand NZD | 0.0% |
| 2010 FY | 672.11 Thousand NZD | 5.11% |
| 2010 Q4 | 672.11 Thousand NZD | 0.0% |
| 2009 Q4 | 639.44 Thousand NZD | 0.0% |
| 2009 FY | 639.44 Thousand NZD | -15.03% |
| 2008 FY | 752.52 Thousand NZD | 232.75% |
| 2008 Q4 | 752.52 Thousand NZD | 0.0% |
| 2007 FY | 226.15 Thousand NZD | -29.48% |
| 2006 FY | 320.7 Thousand NZD | 20.7% |
| 2005 FY | 265.7 Thousand NZD | 0.0% |
| 2005 Q4 | 265.7 Thousand NZD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Australian Clinical Labs Limited | 415.29 Million AUD | 97.158% |
| BCAL Diagnostics Limited | 3.67 Million AUD | -220.953% |
| Genetic Signatures Limited | 6.18 Million AUD | -90.848% |
| Genetic Technologies Limited | 4.35 Million AUD | -170.931% |
| Healius Limited | 1.94 Billion AUD | 99.392% |
| Imagion Biosystems Limited | 8.37 Million AUD | -40.931% |
| Integral Diagnostics Limited | 442.56 Million AUD | 97.333% |
| INOVIQ Ltd | 1.71 Million AUD | -586.414% |
| Microba Life Sciences Limited | 16.82 Million AUD | 29.851% |
| Monash IVF Group Limited | 261.81 Million AUD | 95.492% |
| Rhythm Biosciences Limited | 651.54 Thousand AUD | -1711.399% |
| Sonic Healthcare Limited | 6.75 Billion AUD | 99.825% |